StonvexLoading…
StonvexStonvexStonvexCore line items from JILL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $596.55M | $458.14M | $307.61M | $153.62M |
Operating Income | $50.61M | $50.77M | $35.84M | $19.06M |
Net Income | $27.89M | $31.41M | $10.52M | $11.69M |
EPS (Diluted) | $1.82 | $2.05 | $1.45 | $0.76 |
Total Assets | $450.22M | $458.00M | $436.51M | $432.90M |
Total Liabilities | $328.72M | $328.95M | $315.01M | $320.92M |
Cash & Equivalents | $41.02M | $58.01M | $45.52M | $31.25M |
Free Cash Flow OCF − CapEx | $25.21M | $36.24M | $20.21M | $3.10M |
Shares Outstanding | 14.87M | 15.12M | 15.23M | 15.28M |